logo
  

Honest Company Posts Adj. EBITDA Loss In Q2; Stock Down

The Honest Company (HNST) reported its seventh consecutive quarter of year-over-year revenue and volume growth. However, the company's adjusted loss per share for the quarter came in below analysts' estimate. Looking forward, the company said it continues to have confidence in its three year strategic plan, Strategy 2023.

On a non-GAAP basis, loss per share was $0.23 for the second quarter of 2021. On average, nine analysts polled by Thomson Reuters expected the company to report a loss per share of $0.14, for the quarter. Analysts' estimates typically exclude special items. Adjusted EBITDA was a loss of $0.8 million for the second quarter of 2021 compared to a gain of $3.5 million during the second quarter of 2020.

Second quarter net loss was $20.0 million, compared to net loss of $0.4 million, a year ago. Net loss per share was $0.17 compared to a loss of $0.01.

Second quarter revenue grew 3% to $74.58 million from $72.35 million, prior year. Excluding an estimated $3.7 million COVID-19 stock-up impact primarily in Diapers and Wipes in the prior year period, revenue growth was 9%, for the quarter. Analysts expected revenue of $79.52 million, for the quarter.

The company ended the second quarter of 2021 with $95.1 million in cash, cash equivalents and short-term investments.

Shares of Honest Company were down nearly 7% in pre-market trade on Friday.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
MTD Products Inc. is recalling 1,774 units of walk-behind self-propelled lawn mowers for potential risk of fire hazard, a statement by the U.S. Consumer Product Safety Commission (CPSC) showed. The company said the lawn mower can leak fuel when it is stored in the upright (vertical) storage position to pose a fire hazard. Nike Inc. announced its plans to exit the Russian market completely following Russia's ongoing war against Ukraine, reports said. The sportswear major, with more than 100 stores in the country, had suspended operations there in March. Earlier in March, while suspending operations temporarily, the company had said its customers that it couldn't guarantee product shipments. The U.S. Food and Drug Administration unveiled its action plan to advance drug development for rare neurodegenerative diseases, including Amyotrophic Lateral Sclerosis or ALS, in five years. The FDA plans specific actions such as regulatory science initiatives, enhancements to existing programs and new policy initiatives for the purpose. It will use public-private partnerships...
Follow RTT